Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4068 results

Sort By:

Normobaric Oxygen Therapy in Colorectal Cancer Patients

Study ID: NCT06946004
Start Date: 2025-11-01
End Date: 2028-11-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

254

Intervention / Treatment

Normobaric oxygen therapy

Normobaric oxygen therapy

Sponsor

4th Military Clinical Hospital with Polyclinic, Poland

Source: clinicaltrials.gov

Share:
Add to list

MedSMA℞T Mobile ED

Study ID: NCT06848504
Start Date: 2026-06
End Date: 2028-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

244

Intervention / Treatment

MedSMA℞T Mobile

Sponsor

The Funuch Abraham

Source: clinicaltrials.gov

Share:
Add to list

A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC

Study ID: NCT06908304
Start Date: 2025-07-28
End Date: 2027-07-29
Study Type

Interventional

Study Phase

Phase3

No. of Participants

300

Intervention / Treatment

6-Thio-2'-Deoxyguanosine

Cemiplimab

Docetaxel

Vinorelbine

Gemcitabine alone

Sponsor

Maia Biotechnology

Source: clinicaltrials.gov

Share:
Add to list

A Clinical Study Investigating the Therapeutic Effects and Safety of an Investigational Cell Therapy Given With and Without an Additional Investigational Product in Males With Testicular Cancer or a Form of Cancer That Developed From Sperm

Study ID: NCT06940804
Start Date: 2025-07
End Date: 2042-06
Study Type

Interventional

Study Phase

Phase2

No. of Participants

150

Intervention / Treatment

CLDN6 CAR-T

CLDN6 RNA-LPX

Sponsor

BioNTech SE

Source: clinicaltrials.gov

Share:
Add to list

Glucose and Blood Pressure During Pregnancy

Study ID: NCT04979312
Start Date: 2025-08
End Date: 2026-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

LabClasp

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

The Safety and Efficacy of NouvSoma001 in Ischemic Stroke

Study ID: NCT06612710
Start Date: 2025-07-30
End Date: 2027-11-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

69

Intervention / Treatment

extracellular vesicles derived from human induced neural stem cell for intravenous injection

a placebo of extracellular vesicles derived from human induced neural stem cell for intravenous injection

Sponsor

Wei Wang

Source: clinicaltrials.gov

Share:
Add to list

New Care Pathway Using Automated Dynamic Laximetry

Study ID: NCT07028476
Start Date: 2025-09-01
End Date: 2027-09-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Automated Dynamic Laximetry

MRI

Sponsor

University Hospital, Angers

Source: clinicaltrials.gov

Share:
Add to list

Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

Study ID: NCT07018869
Start Date: 2025-10-21
End Date: 2029-03-23
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1057

Intervention / Treatment

Intervention website access

Control website access

Interview

Administration questionnaire

Sponsor

SWOG Cancer Research Network

Source: clinicaltrials.gov

Share:
Add to list

Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke

Study ID: NCT06303869
Start Date: 2025-09
End Date: 2029-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

Deep Brain Stimulation (DBS) of the Motor Thalamus

Sponsor

Jorge Gonzalez-Martinez

Source: clinicaltrials.gov

Share:
Add to list

Glofitamab in Real Life

Study ID: NCT06994169
Start Date: 2025-08-01
End Date: 2026-11-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

250

Intervention / Treatment

Glofitamab

Sponsor

The Lymphoma Academic Research Organisation

Source: clinicaltrials.gov

Share:
Add to list